Hsiang-Wen Tseng is Director of Preclinical Development at APRINOIA Therapeutics Inc. The majors and specialties of Hsiang-Wen Tseng are focus on disease animal models for pharmacodynamics evaluation of drug development. In addition, he also developed toxicology studies by preclinical toxicity models and in vitro alternative non-animal methods for cosmetics and chemicals. Hsiang-Wen has been managing the Pharmacodynamics Development and Animal Laboratory in Industrial Technology Research Institute (ITRI), the world¡¯s top R&D institutes for developing and commercializing advanced technologies in Taiwan. He received the Bachelor of Pharmacy at Taipei Medical University and obtained his MS a...